Literature DB >> 22712836

Serum miR-29a as a marker of multiple myeloma.

Sabina Sevcikova, Lenka Kubiczkova, Lenka Sedlarikova, Ondrej Slaby, Roman Hajek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22712836     DOI： 10.3109/10428194.2012.704030

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  24 in total

1.  Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.

Authors:  Junhua Wu; Liwen Li; Chunping Jiang
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

2.  Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis.

Authors:  Quan Li; Long Liu; Weiming Li
Journal:  Tumour Biol       Date:  2014-07-23

3.  Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma.

Authors:  Xiaoyan Qu; Min Zhao; Shuang Wu; Wenjun Yu; Jiaren Xu; Ji Xu; Jianyong Li; Lijuan Chen
Journal:  Med Oncol       Date:  2014-09-13       Impact factor: 3.064

Review 4.  MicroRNAome genome: a treasure for cancer diagnosis and therapy.

Authors:  Ioana Berindan-Neagoe; Paloma del C Monroig; Barbara Pasculli; George A Calin
Journal:  CA Cancer J Clin       Date:  2014-08-07       Impact factor: 508.702

5.  Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.

Authors:  Mu Hao; Meirong Zang; Erik Wendlandt; Yan Xu; Gang An; Dasen Gong; Fei Li; Fang Qi; Yanru Zhang; Ye Yang; Fenghuang Zhan; Lugui Qiu
Journal:  Int J Cancer       Date:  2014-09-19       Impact factor: 7.396

6.  Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Lenka Kubiczkova; Fedor Kryukov; Ondrej Slaby; Elena Dementyeva; Jiri Jarkovsky; Jana Nekvindova; Lenka Radova; Henrieta Greslikova; Petr Kuglik; Eva Vetesnikova; Ludek Pour; Zdenek Adam; Sabina Sevcikova; Roman Hajek
Journal:  Haematologica       Date:  2013-11-15       Impact factor: 9.941

Review 7.  MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.

Authors:  Sara Correia Marques; Maria Bach Laursen; Julie Støve Bødker; Malene Krag Kjeldsen; Steffen Falgreen; Alexander Schmitz; Martin Bøgsted; Hans Erik Johnsen; Karen Dybkaer
Journal:  Oncotarget       Date:  2015-01-01

Review 8.  Targeting microRNA in hematologic malignancies.

Authors:  Zhen Han; Steven T Rosen; Christiane Querfeld
Journal:  Curr Opin Oncol       Date:  2020-09       Impact factor: 3.915

9.  Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.

Authors:  Lenka Besse; Lenka Sedlarikova; Fedor Kryukov; Jana Nekvindova; Lenka Radova; Ondrej Slaby; Petr Kuglik; Martina Almasi; Miroslav Penka; Marta Krejci; Zdenek Adam; Ludek Pour; Sabina Sevcikova; Roman Hajek
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

10.  Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations.

Authors:  Yunhui Xiang; Liuyun Zhang; Pinpin Xiang; Juan Zhang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.